CE vs CSBR · rev $10.28B vs P/E 16, rev $56.9M
Celanese Corporation (CE) versus Champions Oncology Inc (CSBR) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
CE currently screens at market cap $5.92B. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Not investment advice. Open the CE and CSBR stock pages for the full models.
Not investment advice.